Complete Story
 

01/25/2014

TEVA Announces Updates to Oncology Biologic Portfolio

GRANIX™ is a leukocyte growth factor indicated for reduction in the duration of severe neutropenia in patients with non-myeloid malignancies receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia. READ MORE